Skip to content
Inciteful Med

Understanding Your Diagnosis Report

Last updated:

Next-Generation Sequencing and the van der Burgt clinical criteria are used together to diagnose Noonan syndrome. While a pathogenic genetic variant confirms the diagnosis, up to 20% of clinically diagnosed patients have a negative genetic test because some causal genes remain undiscovered.

Key Takeaways

  • • Next-Generation Sequencing (NGS) is a highly accurate test used to scan multiple genes at once to confirm a Noonan syndrome diagnosis.
  • • A negative genetic test does not rule out Noonan syndrome, as 10-20% of individuals with clinical features do not have a known genetic mutation.
  • • Doctors use the van der Burgt criteria to score clinical features like facial characteristics, heart findings, and short stature.
  • • Genetic testing is crucial for distinguishing Noonan syndrome from other RASopathies, which guides long-term health monitoring and family planning.

Diagnosing Noonan syndrome (NS) can be a complex process because its features often overlap with other conditions [1]. Whether you’re navigating a new diagnosis for yourself or your child, understanding your clinical paperwork and genetic test results is key [2][3].

Reading Your Genetic Report

To confirm a clinical diagnosis, doctors use Next-Generation Sequencing (NGS) [4][5]. This is a highly accurate blood or saliva test that scans a “panel” of many genes at once [4][6].

When you read your report, you may see:

  • Pathogenic Variant: This confirms the diagnosis and identifies the specific mutated gene (such as PTPN11, SOS1, or RAF1) [7].
  • Variant of Uncertain Significance (VUS): A genetic change was found, but there isn’t enough medical evidence yet to know if it causes Noonan syndrome [6].
  • Negative Result: Importantly, about 10-20% of individuals who clinically have Noonan syndrome will have a “negative” genetic test [2]. This does not mean you don’t have the condition; it just means the specific gene responsible hasn’t been discovered yet.

Knowing your exact mutation helps doctors predict risks and guides family planning [6][8].

The Clinical Yardstick: Van der Burgt Criteria

Even with genetic testing, doctors still look at the van der Burgt criteria, a scoring system that looks at several categories of symptoms and labels them as either Major or Minor [9][10].

Your clinical paperwork may note specific combinations of these features:

  • Facial Features: Distinctive eye spacing (hypertelorism) and ear position are considered major features, especially in children [11][12].
  • Heart Findings: A narrowing of the pulmonary valve (pulmonary valve stenosis) is a major cardiac sign [13][14].
  • Height: Being significantly shorter than average (below the 3rd percentile) is a major growth criterion [15][16].
  • Chest Shape: A sunken or protruding chest (pectus excavatum/carinatum) is often included as a supportive finding [17][11].

Appendix: Noonan Look-Alikes

Because Noonan syndrome belongs to a family of related disorders called RASopathies, doctors must distinguish it from “look-alike” conditions [18][19].

  • NSML (Noonan Syndrome with Multiple Lentigines): Features small, dark brown skin spots (lentigines) that look like freckles but appear in large numbers [20][21].
  • Cardiofaciocutaneous (CFC) Syndrome: Often involves severe skin issues (like very dry or thickened skin), sparse eyebrows, and significant feeding difficulties in infancy [21][12].
  • Costello Syndrome: Individuals often have very soft, loose-feeling skin on the hands and feet, and a higher risk for certain types of heart muscle thickening [22][23].

Distinguishing between these is one of the most important reasons to pursue genetic testing, as each condition has its own set of long-term health considerations [24][1].

Return to Home Page

Frequently Asked Questions

What does a pathogenic variant mean on a Noonan syndrome genetic test?
A pathogenic variant confirms the diagnosis of Noonan syndrome. It means the specific genetic mutation causing the condition, such as a change in the PTPN11, SOS1, or RAF1 gene, has been clearly identified.
Can I still have Noonan syndrome if my genetic test is negative?
Yes, about 10-20% of people who meet the clinical criteria for Noonan syndrome receive a negative genetic test result. This does not mean you don't have the condition; it simply means the specific gene responsible hasn't been discovered yet.
What is a Variant of Uncertain Significance (VUS)?
A Variant of Uncertain Significance (VUS) means a genetic change was found, but there isn't enough medical evidence yet to know if it causes Noonan syndrome. Your medical team will help you understand what this means for your specific case as new research emerges.
What are the van der Burgt criteria?
The van der Burgt criteria is a clinical scoring system doctors use to help diagnose Noonan syndrome. It evaluates major and minor physical features, including distinctive eye and ear spacing, heart abnormalities like pulmonary valve stenosis, short stature, and chest shape.
How do doctors tell Noonan syndrome apart from look-alike conditions?
Doctors rely heavily on targeted genetic testing (Next-Generation Sequencing) to identify the exact gene mutation. They also look closely at specific physical differences, such as unique skin features or heart issues, to distinguish Noonan syndrome from related RASopathies like CFC or Costello syndrome.

Questions for Your Doctor

  • • Which of the 'Major' and 'Minor' van der Burgt criteria did my child (or I) meet?
  • • Since many RASopathies look similar, how did the genetic testing (NGS) help confirm it is specifically Noonan syndrome?
  • • Were there any 'variants of uncertain significance' (VUS) found in the genetic report that we should know about?
  • • How do the heart findings, like pulmonary stenosis versus cardiomyopathy, help confirm this diagnosis over a different RASopathy?
  • • Are there specific skin or hair features we should watch for that might point toward a different related condition?

Questions for You

  • • Has anyone else in the family ever been told they have 'Noonan-like' features or unexplained heart issues?
  • • When I look at old photos of myself or my child, do the facial features seem to have changed or become more subtle over time?
  • • What are my main goals for getting a definitive genetic diagnosis (e.g., better treatment, understanding risks, or family planning)?
  • • Do I feel confident that my current doctor can distinguish between the different types of RASopathies?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    The RASopathies: Biology, genetics and therapeutic options.

    Longo JF, Carroll SL

    Advances in cancer research 2022; (153()):305-341 doi:10.1016/bs.acr.2021.07.007.

    PMID: 35101235
  2. 2

    Noonan syndrome - a new survey.

    Tafazoli A, Eshraghi P, Koleti ZK, Abbaszadegan M

    Archives of medical science : AMS 2017; (13(1)):215-222 doi:10.5114/aoms.2017.64720.

    PMID: 28144274
  3. 3

    Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.

    Linglart L, Gelb BD

    American journal of medical genetics. Part C, Seminars in medical genetics 2020; (184(1)):73-80 doi:10.1002/ajmg.c.31765.

    PMID: 32022400
  4. 4

    Expanding the Genetic Landscape of RASopathies: Significance of Including NF1 in Targeted Panels.

    Kendir-Demirkol Y, Yeter B, Eser M, Yarar MH

    Molecular syndromology 2025; (16(6)):540-549 doi:10.1159/000545192.

    PMID: 41078618
  5. 5

    Noonan Syndrome in South Africa: Clinical and Molecular Profiles.

    Tekendo-Ngongang C, Agenbag G, Bope CD, et al.

    Frontiers in genetics 2019; (10()):333 doi:10.3389/fgene.2019.00333.

    PMID: 31057598
  6. 6

    The Genetic Architecture of Congenital Heart Disease in Neonatal Intensive Care Unit Patients-The Experience of University Medical Centre, Ljubljana.

    Peterlin A, Bertok S, Writzl K, et al.

    Life (Basel, Switzerland) 2024; (14(9)) doi:10.3390/life14091118.

    PMID: 39337901
  7. 7

    Non-RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome.

    Kim GJ, Malaquias AC, Bertola DR, et al.

    American journal of medical genetics. Part A 2026; (200(3)):661-672 doi:10.1002/ajmg.a.64291.

    PMID: 41137536
  8. 8

    Management of failed Chiari decompression and intrasyringeal hemorrhage in Noonan syndrome: illustrative cases.

    Falls CJ, Page PS, Greeneway GP, et al.

    Journal of neurosurgery. Case lessons 2022; (3(4)).

    PMID: 36130568
  9. 9

    Joint involvement in Noonan syndrome. A retrospective paediatric descriptive study.

    Le Quellec A, Edouard T, Audebert-Bellanger S, et al.

    Joint bone spine 2022; (89(1)):105270 doi:10.1016/j.jbspin.2021.105270.

    PMID: 34534690
  10. 10

    Clinical and Genetic Characterization of Noonan Syndrome in a Romanian Cohort from Transylvania: Details on PTPN11 c.922A>G Variant and Phenotypic Spectrum.

    Nazarie FV, Miclea D, Șufană C, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(21)) doi:10.3390/diagnostics15212753.

    PMID: 41226044
  11. 11

    Noonan syndrome with somnambulism: A rare case report.

    Sahu S, Chaudhury S, Saldanha D

    Industrial psychiatry journal 2020; (29(2)):339-341 doi:10.4103/ipj.ipj_84_19.

    PMID: 34158723
  12. 12

    Antenatal diagnosis of cardio-facio-cutaneous syndrome: Prenatal characteristics and contribution of fetal facial dysmorphic signs in utero. About a case and review of literature.

    Biard JM, Steenhaut P, Bernard P, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2019; (240()):232-241 doi:10.1016/j.ejogrb.2019.06.035.

    PMID: 31336229
  13. 13

    Coronary artery ectasia in Noonan syndrome: Report of an individual with SOS1 mutation and literature review.

    Calcagni G, Baban A, De Luca E, et al.

    American journal of medical genetics. Part A 2016; (170(3)):665-9 doi:10.1002/ajmg.a.37505.

    PMID: 26686981
  14. 14

    Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan.

    Lee CL, Tan LTH, Lin HY, et al.

    American journal of medical genetics. Part A 2020; (182(2)):357-364 doi:10.1002/ajmg.a.61429.

    PMID: 31837205
  15. 15

    Noonan syndrome and Noonan-like syndrome with loose anagen hair: rare phenotypes may emerge during follow-up.

    Liu Z, Lai J, Song F

    Translational pediatrics 2024; (13(7)):1161-1168 doi:10.21037/tp-24-113.

    PMID: 39144424
  16. 16

    Case report: A de novo RASopathy-causing SHOC2 variant in a Chinese girl with noonan syndrome-like with loose anagen hair.

    Wang Q, Cheng S, Fu Y, Yuan H

    Frontiers in genetics 2022; (13()):1040124 doi:10.3389/fgene.2022.1040124.

    PMID: 36579329
  17. 17

    Modified Nuss procedure versus Ravitch in concurrent repair of pectus deformity and open-heart surgery.

    Davari H, Asbagh RA, Hosseini S, et al.

    Asian cardiovascular & thoracic annals 2026; (34(1)):33-42 doi:10.1177/02184923251404220.

    PMID: 41364214
  18. 18

    Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.

    Ueda K, Yaoita M, Niihori T, et al.

    American journal of medical genetics. Part A 2017; (173(9)):2346-2352 doi:10.1002/ajmg.a.38337.

    PMID: 28650561
  19. 19

    RASopathies and cardiac manifestations.

    Hilal N, Chen Z, Chen MH, Choudhury S

    Frontiers in cardiovascular medicine 2023; (10()):1176828 doi:10.3389/fcvm.2023.1176828.

    PMID: 37529712
  20. 20

    Dermatological manifestations, management, and care in RASopathies.

    Kavamura MI, Leoni C, Neri G

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(4)):452-458 doi:10.1002/ajmg.c.32027.

    PMID: 36541891
  21. 21

    RASopathies: Dermatologists' viewpoints.

    Palit A, Inamadar AC

    Indian journal of dermatology, venereology and leprology 2022; (88(4)):452-463.

    PMID: 35138057
  22. 22

    Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies.

    Jhang WK, Choi JH, Lee BH, et al.

    Pediatric cardiology 2016; (37(8)):1539-1547 doi:10.1007/s00246-016-1468-6.

    PMID: 27554254
  23. 23

    Management of nutritional and gastrointestinal issues in RASopathies: A narrative review.

    Onesimo R, Giorgio V, Viscogliosi G, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(4)):478-493 doi:10.1002/ajmg.c.32019.

    PMID: 36515923
  24. 24

    Clinical features and molecular genetics of patients with RASopathies: expanding the phenotype with rare genes and novel variants.

    Yılmaz Uzman C, Gürsoy S, Özkan B, et al.

    European journal of pediatrics 2024; (184(1)):108 doi:10.1007/s00431-024-05825-8.

    PMID: 39725732

This page is intended to help you understand Noonan syndrome diagnostic criteria and genetic reports for educational purposes only. Always consult your geneticist or pediatrician to interpret your specific medical results.

Stay up to date

Get notified when new research about Noonan syndrome is published.

No spam. Unsubscribe anytime.